NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Hey the guy who stickied Adam Feuersteins lie about conversations with UCLA and nonsense about ATL-DC, wants to chime in 🥳

- Market did not react. Not even a brief pop over $1.

Market DID react. Market Makers have spoofed continously since at least 2015-16.

- No results yet 8 months later

NWBO has filed MAA under 150 days accelerated approval assessment with possibility of up to 60 days RFI. We are hitting around 190 days, so its still within MHRA timeline.

- IHUB collectively has zero knowledge of MHRA reply schedules, proved by thousands of erroneous posts

.

rj received MHRA confirmation validation date was January 24th. No more knowledge is needed. But I am glad you feel you have the knowledge to point that out to us, knowing how many times you've chosen to be wrong in the past.

- Still expect rejection due to mediocre results, lack of patient level data, etc.

Of course you do. You've never been one to be pursuaded by facts and factual circumstances.

Spoofing lawsuit is just a distraction. Even if nwbo could prove spoofing, they face the problem that spoofing is a short term trading strategy. Can they convince a judge/jury that a short term trading strategy has caused long term price suppression? I doubt it.

Of course you doubt it. Thats great odds for longs. A spoofing lawsuit taken by Laura Posner finalist of years best lawyer with a record settlement for fraud and having amended 262 pages of loss of causation data, among it referencing to book of professor that explains spoofing has long term consequences. You just continue to doubt Jerry.

Price depression is caused by 400,000 shares per day printed by Linda Powers. Not evil forces.

No its not. Spoofing incidents are evidence and going from $1.81 to $0.38 on the day successful results are announced are nothing about printing of shares to do.

Flaskworks is irrelevant in the short term. Wasn't part of the trial, so it can't be part of an approval. No update on any attempt at an equivalency trial/study.

They have run biosimilar test for at least two years and we have deficated statements from Advent employee that is working on biosimilarity tests on Eden. They don't need equivalency trial. Neither MHRA nor FDA. Both regulators have stated so and I have supplied the links and screenshots as many times as people have tried to lie about it.

Other solid tumors were not part of the P3 trial, so can't be part of an approval.

No one expect that either.

Poly was not part of the P3 trial, so can't be part of an approval.

Poly-iclc can be provided off-label as Linda Liau have stated.

nwbo -29% year over year, while SPY +21%. Opportunity cost matters to real investors

Longs know that share price is spoofed and does not reflect fair market price.

No fresh bull arguments. No fresh bear arguments. Just the same tired narratives beaten to death day after day.

We don't need fresh bull arguments. We just need the truthful ones. If you are tired listening to them, then don't repeat the false ones and thus making longs having to counter with theirs.